-
Junshi Biosciences Announces the Completion of First Patient Dosing in the Phase 3 Clinical Trial of Junshi Biosciences Announces the Completion of First Patient Dosing in the Phase 3 Clinical Trial of JS207 in Combination with JS007 for the First-Line Treatment of Advanced Hepatocellular Carcinoma ...资讯2026-10-29
最热
推荐
- Regnology Research Maps Route From AI Pilots to Production in Regulatory Reporting
- 琪朗健康照明“小太阳”护眼公益计划西安启动 专业光学技术守护青少年视力健康
- 富思特联合主办全球银发经济产业峰会 携手多方共拓健康安全赛道新机遇
- Altimetrik与SLK Software强强联合,打造以AI为核心的工程服务巨头
- Clean Core and CNL sign Cost Share Project under CNRI to advance Thorium-Based ANEEL™ Fuel
- 洲际酒店集团发布2025年第三季度业绩报告
- 星期零多款植物基产品上线朴朴超市和叮咚买菜
- 人民法院同案同判规范化,Alpha法律数据库为法律人提供技术支持
- 活力健步走 健康伴我行:农发行常德市分行本级工会开展健步走活动
- BitMEX Report Finds Crypto Perpetuals Enter Post-Yield Era
